Imagen de Portada
Código QR

UroPipeline.

Publicado en:Urology Times Vol. 48; no. 9; pp. 19 - 20
Autor principal: BRODERICK, JASON M.
Formato: Journal Article
Publicado: MJH Life Sciences Sep2020
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=146331019&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 146331019
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00939722
        URO
      jtl: Urology Times
      issn: 00939722
      maglogo: N
    pubinfo:
      dt: Sep2020
      vid: 48
      iid: 9
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        146331019
        146331019
      ppf: 19
      ppct: 1
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: UroPipeline.
      aug:
        au: BRODERICK, JASON M.
      sug:
        subj:
          Urologic Care
          Antibodies, Monoclonal Therapeutic Use
          United States Food and Drug Administration
          Bladder Neoplasms Drug Therapy
          Liquid Biopsy
          Prostatic Neoplasms, Castration-Resistant Drug Therapy
          Treatment Outcomes
          Urinalysis
          Prostatic Neoplasms Diagnosis
          Antineoplastic Agents Therapeutic Use
          Prostatic Neoplasms Drug Therapy
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N